Renal denervation suppresses coronary hyperconstricting responses after drug-eluting stent implantation in pigs in vivo through the kidney-brain-heart axis

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 37, Issue 10, 2017, Pages 1869-1880

  Uzuka, Hironori ^a   Matsumoto, Yasuharu ^a   Nishimiya, Kensuke ^a,b   Ohyama, Kazuma ^a   Suzuki, Hideaki ^a,c   Amamizu, Hirokazu ^a   Morosawa, Susumu ^a   Hirano, Michinori ^a   Shindo, Tomohiko ^a   Kikuchi, Yoku ^a   Hao, Kiyotaka ^a   Shiroto, Takashi ^a   Ito, Kenta ^a   Takahashi, Jun ^a   Fukuda, Koji ^a   Miyata, Satoshi ^a   Funaki, Yoshihito ^d   Ishibashi Ueda, Hatsue ^e   Yasuda, Satoshi ^e   Shimokawa, Hiroaki ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c IMPERIAL COLLEGE LONDON   (United Kingdom)

^d TOHOKU UNIVERSITY   (Japan)

^e NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

Autonomic nervous system; Blood pressure; Coronary vessels; Nerve fibers; Renal artery; Stents

Indexed keywords

ALPHA 2A ADRENERGIC RECEPTOR; BRADYKININ; NERVE GROWTH FACTOR; NEUROPEPTIDE Y; RHO KINASE; SEROTONIN;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIAL WALL THICKNESS; ARTICLE; AUTORADIOGRAPHY; BLOOD VESSEL TONE; BRAIN; CELL INFILTRATION; CONTROLLED STUDY; CORONARY ANGIOGRAPHY; CORONARY ARTERY CONSTRICTION; CORONARY STENTING; DIASTOLIC BLOOD PRESSURE; ENZYME ACTIVATION; HEART; HEART INNERVATION; IN VIVO STUDY; INFLAMMATORY CELL; KIDNEY ARTERY; KIDNEY DENERVATION; LEFT CORONARY ARTERY; MORPHOMETRY; MUSCLE SYMPATHETIC NERVE ACTIVITY; NONHUMAN; PIG; PLASMA RENIN ACTIVITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SOLITARY TRACT NUCLEUS; SYSTOLIC BLOOD PRESSURE; VASA VASORUM; ADVERSE EFFECTS; ANIMAL; BLOOD PRESSURE; CORONARY BLOOD VESSEL; DENERVATION; DRUG ELUTING STENT; HEART RATE; INNERVATION; KIDNEY; METABOLISM; PHYSIOLOGY; VASOCONSTRICTION;

ANIMALS; BLOOD PRESSURE; BRAIN; CORONARY VESSELS; DENERVATION; DRUG-ELUTING STENTS; HEART; HEART RATE; KIDNEY; RHO-ASSOCIATED KINASES; SWINE; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION;

EID: 85031016790     PISSN: 10795642     EISSN: 15244636     Source Type: Journal    
DOI: 10.1161/ATVBAHA.117.309777     Document Type: Article

References (40)

1. Lüscher TF, Steffel J, Eberli FR, Joner M, Nakazawa G, Tanner FC, Virmani R. Drug-eluting stent and coronary thrombosis: biological mechanisms and clinical implications. Circulation. 2007;115:1051-1058. doi: 10.1161/CIRCULATIONAHA.106.675934.
2. Aizawa K, Yasuda S, Takahashi J, Takii T, Kikuchi Y, Tsuburaya R, Ito Y, Ito K, Nakayama M, Takeda M, Shimokawa H. Involvement of rho-kinase activation in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in patients with coronary artery disease. Circ J. 2012;76:2552-2560.
3. Togni M, Windecker S, Cocchia R, Wenaweser P, Cook S, Billinger M, Meier B, Hess OM. Sirolimus-eluting stents associated with paradoxic coronary vasoconstriction. J Am Coll Cardiol. 2005;46:231-236. doi: 10.1016/j.jacc.2005.01.062.
4. Ong P, Athanasiadis A, Perne A, Mahrholdt H, Schäufele T, Hill S, Sechtem U. Coronary vasomotor abnormalities in patients with stable angina after successful stent implantation but without in-stent restenosis. Clin Res Cardiol. 2014;103:11-19. doi: 10.1007/s00392-013-0615-9.
5. Tsuburaya R, Takahashi J, Nakamura A, et al; NOVEL Investigators. Beneficial effects of long-acting nifedipine on coronary vasomotion abnormalities after drug-eluting stent implantation: the NOVEL study. Eur Heart J. 2016;37:2713-2721. doi: 10.1093/eurheartj/ehw256.
6. Serruys PW, Chevalier B, Dudek D, et al. A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial. Lancet. 2015;385:43-54. doi: 10.1016/S0140-6736(14)61455-0.
7. Shimokawa H, Sunamura S, Satoh K. RhoA/Rho-kinase in the cardiovascular system. Circ Res. 2016;118:352-366. doi: 10.1161/CIRCRESAHA.115.306532.
8. Kandabashi T, Shimokawa H, Miyata K, Kunihiro I, Kawano Y, Fukata Y, Higo T, Egashira K, Takahashi S, Kaibuchi K, Takeshita A. Inhibition of myosin phosphatase by upregulated rho-kinase plays a key role for coronary artery spasm in a porcine model with interleukin-1beta. Circulation. 2000;101:1319-1323.
9. Tsuburaya R, Yasuda S, Shiroto T, Ito Y, Gao JY, Aizawa K, Kikuchi Y, Ito K, Takahashi J, Ishibashi-Ueda H, Shimokawa H. Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in vivo: possible involvement of Rho-kinase pathway. Eur Heart J. 2012;33:791-799. doi: 10.1093/eurheartj/ehr145.
10. Shimokawa H. 2014 Williams Harvey lecture: importance of coronary vasomotion abnormalities-from bench to bedside. Eur Heart J. 2014;35:3180-3193. doi: 10.1093/eurheartj/ehu427.
11. Shimokawa H, Ito A, Fukumoto Y, Kadokami T, Nakaike R, Sakata M, Takayanagi T, Egashira K, Takeshita A. Chronic treatment with interleukin-1 beta induces coronary intimal lesions and vasospastic responses in pigs in vivo. The role of platelet-derived growth factor. J Clin Invest. 1996;97:769-776. doi: 10.1172/JCI118476.
12. Nishimiya K, Matsumoto Y, Shindo T, Hanawa K, Hasebe Y, Tsuburaya R, Shiroto T, Takahashi J, Ito K, Ishibashi-Ueda H, Yasuda S, Shimokawa H. Association of adventitial vasa vasorum and inflammation with coronary hyperconstriction after drug-eluting stent implantation in pigs in vivo. Circ J. 2015;79:1787-1798. doi: 10.1253/circj.CJ-15-0149.
13. Nishimiya K, Matsumoto Y, Takahashi J, Uzuka H, Wang H, Tsuburaya R, Hao K, Ohyama K, Odaka Y, Miyata S, Ito K, Shimokawa H. Enhanced adventitial vasa vasorum formation in patients with vasospastic angina: assessment with OFDI. J Am Coll Cardiol. 2016;67:598-600. doi: 10.1016/j.jacc.2015.11.031.
14. Lanza GA, Pedrotti P, Pasceri V, Lucente M, Crea F, Maseri A. Autonomic changes associated with spontaneous coronary spasm in patients with variant angina. J Am Coll Cardiol. 1996;28:1249-1256. doi: 10.1016/S0735-1097(96)00309-9.
15. Nihei T, Takahashi J, Tsuburaya R, Ito Y, Shiroto T, Hao K, Takagi Y, Matsumoto Y, Nakayama M, Miyata S, Sakata Y, Ito K, Shimokawa H. Circadian variation of Rho-kinase activity in circulating leukocytes of patients with vasospastic angina. Circ J. 2014;78:1183-1190.
16. Meller ST, Gebhart GF. A critical review of the afferent pathways and the potential chemical mediators involved in cardiac pain. Neuroscience. 1992;48:501-524.
17. Mahfoud F, Lüscher TF, Andersson B, et al. Expert consensus document from the European Society of Cardiology on catheter-based renal denervation. Eur Heart J. 2013:34:2147-2157. doi: 10.1093/eurheartj/eht154.
18. Cohen-Mazor M, Mathur P, Stanley JR, Mendelsohn FO, Lee H, Baird R, Zani BG, Markham PM, Rocha-Singh K. Evaluation of renal nerve morphological changes and norepinephrine levels following treatment with novel bipolar radiofrequency delivery systems in a porcine model. J Hypert. 2014:32:1678-1691; discussion 1691-1692
19. Mahfoud F, Bakris G, Bhatt DL, Esler M, Ewen S, Fahy M, Kandzari D, Kario K, Mancia G, Weber M, Böhm M. Reduced blood pressure-lowering effect of catheter-based renal denervation in patients with isolated systolic hypertension: data from SYMPLICITY HTN-3 and the global SYMPLICITY registry. Eur Heart J. 2017;38:93-100. doi: 10.1093/eurheartj/ehw325.
20. Böhm M, Mahfoud F, Ukena C, Hoppe UC, Narkiewicz K, Negoita M, Ruilope L, Schlaich MP, Schmieder RE, Whitbourn R, Williams B, Zeymer U, Zirlik A, Mancia G; GSR Investigators. First report of the global SYMPLICITY registry on the effect of renal artery denervation in patients with uncontrolled hypertension. Hypertension. 2015;65:766-774. doi: 10.1161/HYPERTENSIONAHA.114.05010.
21. Azizi M, Pereira H, Hamdidouche I, et al; DENERHTN Investigators. Adherence to antihypertensive treatment and the blood pressure-lowering effects of renal denervation in the renal denervation for hypertension (DENERHTN) trial. Circulation. 2016;134:847-857. doi: 10.1161/CIRCULATIONAHA.116.022922.
22. Polhemus DJ, Gao J, Scarborough AL, Trivedi R, McDonough KH, Goodchild TT, Smart F, Kapusta DR, Lefer DJ. Radiofrequency renal denervation protects the ischemic heart via inhibition of GRK2 and increased nitric oxide signaling. Circ Res. 2016;119:470-480. doi: 10.1161/CIRCRESAHA.115.308278.
23. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, Leon MB, Liu M, Mauri L, Negoita M, Cohen SA, Oparil S, Rocha-Singh K, Townsend RR, Bakris GL; SYMPLICITY HTN-3 Investigators. A controlled trial of renal denervation for resistant hypertension. N Engl J Med. 2014;370:1393-1401. doi: 10.1056/NEJMoa1402670.
24. Nakamura T, Kawahara K, Kusunoki M, Feng Z. Microneurography in anesthetized rats for the measurement of sympathetic nerve activity in the sciatic nerve. J Neurosci Methods. 2003;131:35-39.
25. Schlaich MP, Sobotka PA, Krum H, Lambert E, Esler MD. Renal sympathetic-nerve ablation for uncontrolled hypertension. N Engl J Med. 2009;361:932-934. doi: 10.1056/NEJMc0904179.
26. Nishimiya K, Matsumoto Y, Uzuka H, Ogata T, Hirano M, Shindo T, Hasebe Y, Tsuburaya R, Shiroto T, Takahashi J, Ito K, Shimokawa H. Beneficial effects of a novel bioabsorbable polymer coating on enhanced coronary vasoconstricting responses after drug-eluting stent implantation in pigs in vivo. JACC Cardiovasc Interv. 2016;9:281-291. doi: 10.1016/j.jcin.2015.09.041.
27. Asanome A, Kawabe J, Matsuki M, Kabara M, Hira Y, Bochimoto H, Yamauchi A, Aonuma T, Takehara N, Watanabe T, Hasebe N. Nerve growth factor stimulates regeneration of perivascular nerve, and induces the maturation of microvessels around the injured artery. Biochem Biophys Res Commun. 2014;443:150-155. doi: 10.1016/j.bbrc.2013.11.070.
28. Hao L, Zou Z, Tian H, Zhang Y, Song C, Zhou H, Liu L. Novel roles of perivascular nerves on neovascularization. Neurol Sci. 2015;36:353-360. doi: 10.1007/s10072-014-2016-x.
29. Kandzari DE, Bhatt DL, Brar S, et al. Predictors of blood pressure response in the SYMPLICITY HTN-3 trial. Eur Heart J. 2015;36:219-227. doi: 10.1093/eurheartj/ehu441.
30. Santiago FE, Fior-Chadi DR, Carrettiero DC. Alpha2-adrenoceptor and adenosine A1 receptor within the nucleus tractus solitarii in hypertension development. Auton Neurosci. 2015;187:36-44. doi: 10.1016/j.autneu.2014.11.002.
31. Felder RB. Excitatory and inhibitory interactions among renal a cardiovascular afferent nerves in dorsomedial medulla. Am J Physiol. 1986:250:580-588.
32. El-Mas MM, Abdel-Rahman AA. Aortic barodenervation up-regulates alpha2-adrenoceptors in the nucleus tractus solitarius and rostral ventrolat-eral medulla: an autoradiographic study. Neuroscience. 1997;79:581-590.
33. De Jong W. Noradrenaline: central inhibitory control of blood pressure and heart rate. Eur J Pharmacol. 1974;29:179-181.
34. Totola LT, Alves TB, Takakura AC, Ferreira-Neto HC, Antunes VR, Menani J V, Colombari E, Moreira TS. Commissural nucleus of the solitary tract regulates the antihypertensive effects elicited by moxonidine. Neuroscience. 2013;250:80-91. doi: 10.1016/j.neuroscience.2013.06.065.
35. Li D, Wang Q, Zhang Y, Li D, Yang D, Wei S, Su L, Ye T, Zheng X, Peng K, Zhang L, Zhang Y, Yang Y, Ma S. A novel swine model of spontaneous hypertension with sympathetic hyperactivity responds well to renal denervation. Am J Hypertens. 2016;29:63-72. doi: 10.1093/ajh/hpv066.
36. Mahfoud F, Moon LB, Pipenhagen CA, Jensen JA, Pathak A, Papademetriou V, Ewen S, Linz D, Böhm M. Catheter-based radio-frequency renal nerve denervation lowers blood pressure in obese hypertensive swine model. J Hypertens. 2016;34:1854-1862. doi: 10.1097/HJH.0000000000001021.
37. Stenmark KR, Yeager ME, El Kasmi KC, Nozik-Grayck E, Gerasimovskaya EV, Li M, Riddle SR, Frid MG. The adventitia: essential regulator of vascular wall structure and function. Annu Rev Physiol. 2013;75:23-47. doi: 10.1146/annurev-physiol-030212-183802.
38. Raizner AE, Chahine RA, Ishimori T, Verani MS, Zacca N, Jamal N, Miller RR, Luchi RJ. Provocation of coronary artery spasm by the cold pressor test. Hemodynamic, arteriographic and quantitative angiographic observations. Circulation. 1980;62:925-932.
39. Lee EW, Michalkiewicz M, Kitlinska J, Kalezic I, Switalska H, Yoo P, Sangkharat A, Ji H, Li L, Michalkiewicz T, Ljubisavljevic M, Johansson H, Grant DS, Zukowska Z. Neuropeptide Y induces ischemic angiogenesis and restores function of ischemic skeletal muscles. J Clin Invest. 2003;111:1853-1862. doi: 10.1172/JCI16929.
40. Kanazawa K, Suematsu M, Ishida T, Hirata K, Kawashima S, Akita H, Yokoyama M. Disparity between serotonin- and acetylcholine-provoked coronary artery spasm. Clin Cardiol. 1997;20:146-152.